Table l.
Patient characteristics. All values are median (IQR) or frequency (%)
| No LND (N=81) |
LND (N=177) |
p-value | |
|---|---|---|---|
| Age | 63.6 (56.3, 69.0) | 60.3 (52.4, 68.4) | 0.024 |
| Gender | |||
| Female | 23 (28%) | 54 (31%) | 0.7 |
| Male | 58 (72%) | 123 (69%) | |
| ASA | |||
| I/II | 36 (44%) | 89 (51%) | 0.3 |
| III/IV | 45 (56%) | 86 (49%) | |
| Pathological T Stage | |||
| pT1 | 25 (31%) | 11 (6.2%) | <0.0001 |
| pT2 | 5 (6.2%) | 19 (11%) | |
| >=pT3 | 51 (63%) | 147 (83%) | |
| Pathological N Stage | - | ||
| pN0 | 0 (0%) | 118 (67%) | |
| pN1 | 0 (0%) | 59 (33%) | |
| pNX | 81 (100%) | 0 (0%) | |
| Tumor Size (cm) | 6.0 (3.8, 8.2) | 9.2 (7.0, 11.9) | <0.0001 |
| Histology | |||
| Clear Cell | 79 (98%) | 150 (85%) | 0.003 |
| Other | 2 (2.5%) | 27 (15%) | |
| Motzer Criteria | |||
| Favorable | 29 (44%) | 57 (36%) | 0.3 |
| Unfavorable | 37 (56%) | 100 (64%) | |
| Location | |||
| Right | 52 (64%) | 74 (42%) | 0.001 |
| Left | 29 (36%) | 103 (58%) | |
| Lymphadenopathy | |||
| No | 64 (90%) | 94 (56%) | <0.0001 |
| Yes | 7 (9.9%) | 75 (44%) | |
| Nodal Template | - | ||
| Hilar Only | - | 30 (17%) | |
| Other | - | 147 (83%) | |
| Metastasectomy | |||
| No | 43 (53%) | 126 (72%) | 0.004 |
| Yes | 38 (47%) | 50 (28%) | |
| Site of Metastatic Disease | |||
| Pulmonary only | 33 (41%) | 66 (37%) | 0.6 |
| Any non-pulmonary | 48 (59%) | 111 (63%) | |
| Surgery Type | |||
| Radical | 23 (28%) | 11 (6.2%) | <0.0001 |
| Partial | 58 (72%) | 166 (94%) | |
| Minimally Invasive Surgery | |||
| No | 67 (83%) | 137 (77%) | 0.3 |
| Yes | 14 (17%) | 40 (23%) | |
| Neoadjuvant Therapy | |||
| No | 70 (86%) | 161 (91%) | 0.3 |
| Yes | 11 (14%) | 16 (9%) |